New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 18, 2014
04:55 EDTRHHBY, RHHBY, RHHBY, REPYY, REPYY, REPYYBarclays to hold a conference
Internationals Franchise Conference to be held in June 18-20.
News For RHHBY;REPYY From The Last 14 Days
Check below for free stories on RHHBY;REPYY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 25, 2014
07:35 EDTRHHBYEMA recommends new indication for RoActemra in severe arthritis
Subscribe for More Information
July 24, 2014
06:13 EDTRHHBYRoche reaffirms outlook for 2014
Subscribe for More Information
06:12 EDTRHHBYRoche reports 1H core EPS CHF 7.57 vs. CHF 7.58 last year
Subscribe for More Information
July 23, 2014
11:13 EDTREPYYTalisman Energy resumes, up 10.9% after confirming approach from Repsol
11:00 EDTREPYYTalisman Energy acknowledges Repsol offer
Talisman (TLM) is issuing this press release at the request of Market Surveillance at IIROC on behalf of the Toronto Stock Exchange. The company said, "Talisman acknowledges that it has been approached by Repsol (REPYY) with regards to various transactions. There is no assurance that any transaction will be agreed. Until such time as it is appropriate to make a public announcement on any potential transaction, Talisman does not intend to make any further comment on this matter."
09:17 EDTREPYYOn The Fly: Pre-market Movers
Subscribe for More Information
09:08 EDTRHHBYUltragenyx appoints Sunil Agarwal, M.D. as Chief Medical Officer
Subscribe for More Information
08:39 EDTREPYYRepsol contemplates offer for Talisman Energy, Bloomberg says
Repsol (REPYY) is contemplating making an offer for Talisman Energy (TLM) as it aims to deploy funds it was given as compensation for the loss of its share in YPF (YPF), according to Reuters, citing people familiar with the matter. The sources said that Repsol is working with JPMorgan as it examines making a potential bid. Reference Link
July 22, 2014
17:53 EDTREPYYRepsol exploring bid for Talisman Energy, Bloomberg reports
05:21 EDTRHHBYRoche announces Genentech Avastin granted priority review by FDA
Subscribe for More Information
July 21, 2014
07:11 EDTRHHBYInternational Society of DNA Vaccines to hold a conference
Subscribe for More Information
06:43 EDTRHHBYGrowing market for hepatitis-C treatment prompts legal scramble, WSJ says
Subscribe for More Information
July 20, 2014
15:42 EDTRHHBYRoche not looking for big acquisitions, Reuters says
Subscribe for More Information
July 17, 2014
17:42 EDTRHHBYCepheid says Roche patent suit will not have material adverse impact on results
Subscribe for More Information
July 16, 2014
11:23 EDTRHHBYRoche Alzheimer drug shows mixed results in trial, NYT says
Subscribe for More Information
06:26 EDTRHHBYBristol-Myers lung cancer trials being underestimated, says Citigroup
After building a statistical model of Bristol-Myers' two critical registration trials for Opdivo in lung cancer, Citigroup believes the market is "materially" underestimating both Phase III trials. Citi says potential Opdivo FDA approval in 2015 in lung cancer would give Bristol-Myers an up to two year lead time versus Merck (MRK) and Roche (RHHBY). The firm estimates 2023 Opdivo revenue at $7B and reiterates a Buy rating on Bristol with a $60 price target.
July 15, 2014
05:37 EDTRHHBYGenentech Avastin granted priority review by FDA
Subscribe for More Information
July 14, 2014
11:20 EDTRHHBYExelixis seen as potential target for Roche, TheStreet says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use